Full-Time

Senior Lead Data Manager

Posted on 8/26/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

Compensation Overview

$65.7k - $87.5k/yr

Laval, QC, Canada + 1 more

More locations: Overland Park, KS, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor's Degree in programming, health-related sciences, or relevant field and 5-8 years of Data Management experience. Experience may be considered in lieu of education.
  • Excellent verbal and written communication skills.
  • Professional attitude and strong interpersonal skills.
  • Ability to work well with a multi-disciplinary team of professionals.
  • Client-focused approach to work.
  • Flexible attitude with respect to work assignments and new learning.
  • Ability to prioritize workload.
  • Superior attention to detail.
  • Understanding of clinical research and the relationship of Data Management in the clinical study process.
  • Proven history of continuous improvement.
  • Strong technical aptitude and ability to adapt to multiple data management platforms.
  • Strong knowledge of electronic data capture (EDC) clinical data management systems.
  • Good computer skills (Microsoft Word, Excel, and Power Point) and ability to understand and adapt to various information technology (IT) systems.
  • Fluency in English.
Responsibilities
  • Follow department and company standard operating procedures (SOPs), forms, templates and policies. Provide feedback and update these guidelines as needed.
  • Act as the primary Data Management contact for the client and project team, proactively managing sponsor and interdepartmental expectations.
  • Develop strong client relationships that are driven by consistent study delivery in terms of quality and timeliness.
  • Develop, review, and maintain all study Data Management documentation.
  • Coordinate with Database Developers to ensure effective database build and timely go-live to meet the needs of the project.
  • Ensure the clinical database adheres to Clinical Data Acquisition Standards Harmonization guidelines allowing for optimal SDTM dataset programming. Suggest design for standard and non-standard data collection, identify any gaps in data collection, and challenge collection of unnecessary data.
  • Define electronic case report form (eCRF) and edit check specifications to support data collection and analysis required per protocol.
  • Take responsibility for and guide effective quality control (QC) review and user acceptance testing (UAT) of the clinical database prior to its release into production, including oversight of staff performing these tasks.
  • Delegate and collaborate with Data Managers on data management cleaning activities including listing review, issuing and closing queries, and external vendor data reconciliation per protocol, department and client standards, and International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines within the timelines expected by the client and project team.
  • Ensure data are properly reviewed in accordance with the Data Management Plan (DMP) and department and sponsor guidelines and that cleaning is effective and timely.
  • Track eCRFs to ensure appropriate updates and that all missing or discrepant data are queried appropriately. Monitor key study metrics and provide status reports to the sponsor and project team.
  • Maintain the Data Management documentation for the trial master file (TMF) according to department and Project Management processes.
  • Provide input on study timelines, identify risks, and communicate mitigation strategies to the Project Manager.
  • Provide input into improving the efficiency of data management tasks.
  • Lead and participate in intradepartmental or interdepartmental process and quality improvement initiatives.
  • Oversee direct reports as assigned.
  • Mentor and train other team members and/or develop training materials as needed.

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE